Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica C Hassel

Showing results (161-170 of 272) with videos related to

Pageof 28
Sort By:
Oncoimmunology|September 22, 2017
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)Jessica C Hassel, Huanhuan Jiang, Carolin Bender, et al.
Cancer Treatment Reviews|February 29, 2016
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapyThomas K Eigentler, Jessica C Hassel, Carola Berking, et al.
Frontiers in Oncology|December 9, 2024
Bimodal intensity-modulated radiotherapy in combination with carbon ion therapy (C12) of mucosal melanomas - data of the last decade from Heidelberg University HospitalLukas Bauer, Angela Paul, Sebastian Regnery, et al.
Cancer Treatment Reviews|May 28, 2017
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactionsJessica C Hassel, Lucie Heinzerling, Jens Aberle, et al.
Plos One|April 25, 2014
Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffoldsMichael Behr, Johanna K Kaufmann, Patrick Ketzer, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 23, 2019
Susceptibility-weighted imaging in malignant melanoma brain metastasisDaniel Schwarz, Thomas Niederle, Philipp Münch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 22, 2026
Complete lymph node dissection versus selective lymph node extirpation in melanoma patients with nodal macrometastasis and adjuvant systemic therapyKristine E Mayer, Jessica C Hassel, Jannik Sambale, et al.
Annals of the Rheumatic Diseases|April 1, 2024
Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic diseaseKarolina Gente, Manuel Feisst, Dorothea Marx, et al.
The Journal of Investigative Dermatology|July 17, 2024
Tebentafusp Induces a T-Cell-Driven Rash in Melanocyte-Bearing Skin as an Adverse Event Consistent with the Mechanism of ActionJessica C Hassel, Sarah Stanhope, Alexander Greenshields-Watson, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 2020
Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signatureTsubasa Watanabe, Elke Firat, Jutta Scholber, et al.
Pageof 28

Showing results (161-170 of 272) with videos related to

Sort By:
Pageof 28
Oncoimmunology|September 22, 2017
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)Jessica C Hassel, Huanhuan Jiang, Carolin Bender, et al.
Cancer Treatment Reviews|February 29, 2016
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapyThomas K Eigentler, Jessica C Hassel, Carola Berking, et al.
Frontiers in Oncology|December 9, 2024
Bimodal intensity-modulated radiotherapy in combination with carbon ion therapy (C12) of mucosal melanomas - data of the last decade from Heidelberg University HospitalLukas Bauer, Angela Paul, Sebastian Regnery, et al.
Cancer Treatment Reviews|May 28, 2017
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactionsJessica C Hassel, Lucie Heinzerling, Jens Aberle, et al.
Plos One|April 25, 2014
Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffoldsMichael Behr, Johanna K Kaufmann, Patrick Ketzer, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 23, 2019
Susceptibility-weighted imaging in malignant melanoma brain metastasisDaniel Schwarz, Thomas Niederle, Philipp Münch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 22, 2026
Complete lymph node dissection versus selective lymph node extirpation in melanoma patients with nodal macrometastasis and adjuvant systemic therapyKristine E Mayer, Jessica C Hassel, Jannik Sambale, et al.
Annals of the Rheumatic Diseases|April 1, 2024
Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic diseaseKarolina Gente, Manuel Feisst, Dorothea Marx, et al.
The Journal of Investigative Dermatology|July 17, 2024
Tebentafusp Induces a T-Cell-Driven Rash in Melanocyte-Bearing Skin as an Adverse Event Consistent with the Mechanism of ActionJessica C Hassel, Sarah Stanhope, Alexander Greenshields-Watson, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 2020
Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signatureTsubasa Watanabe, Elke Firat, Jutta Scholber, et al.
Pageof 28